卡前列素氨丁三醇市場 - 按應用（產後出血治療、妊娠流產）、配銷通路（醫院藥房、零售藥房、線上藥房） - 全球預測（2024 - 2032）

Carboprost Tromethamine Market - By Application (Postpartum Hemorrhage Treatment, Pregnancy Abortion), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Global Forecast (2024 - 2032)

出版日期: 2024年03月15日 | 出版商:

Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

由於產後出血(PPH) 和子宮收縮乏力等疾病的盛行率不斷上升，特別是在發展中地區，卡前列素氨丁三醇市場預計從2024 年到2032 年將以7.9% 的複合年成長率成長。根據世界衛生組織的數據，每年約有 1,400 萬名婦女遭受產後出血 (PPH)，導致全球約 7 萬名孕產婦死亡。這些情況對分娩期間的孕產婦健康構成重大風險，需要採取有效的干涉措施來控制出血並預防併發症。產科護理的進步以及醫療保健專業人員對管理 PPH 功效的認知不斷提高，推動了卡前列素氨丁三醇在臨床環境中的採用。

月經失調、不全流產等婦科疾病的治療將進一步刺激市場擴張。隨著醫療保健提供者尋求多種治療方案來解決一系列生殖健康問題，對卡前列素氨丁三醇的需求正在上升。此外，有利的政府措施正在改善孕產婦保健基礎設施並降低孕產婦死亡率，特別是在新興經濟體。

卡前列素氨丁三醇產業分為應用、配銷通路和地區。

預計到2032 年，妊娠流產應用領域的市場佔有率將以8% 的複合年成長率成長。收縮並促進胎兒組織排出。隨著藥物流產作為外科手術的安全和非侵入性替代方案的接受度和可用性不斷提高，對支持該過程的藥物製劑的需求不斷成長，這將促進該領域的成長。

根據配銷通路，線上藥局領域的卡前列素氨丁三醇市場價值預計在預測期內將成長 6.8%。線上藥局提供的便利性和可及性使醫療保健提供者更容易購買卡前列素氨丁三醇等基本藥物，特別是在傳統實體藥房訪問有限的地區。線上藥局提供多種藥品，也使醫療保健專業人員能夠方便地購買卡前列素氨丁三醇以及其他藥物，以簡化採購流程。

亞太地區卡前列素氨丁三醇產業規模將在2024年至2032年間顯著擴張，複合年成長率為8.5%，原因是孕產婦死亡率高，特別是在產科護理機會有限的國家。藥物流產手術的日益普及和生殖保健服務的普及導致產品需求不斷成長。旨在改善孕產婦和生殖保健基礎設施的政府支持性舉措，以及更高的醫療保健支出和意識，將進一步推動區域市場的成長。

產業生態系統分析
產業影響力
- 成長動力
  - 產後出血盛行率上升
  - 政府和各種組織的措施不斷增加
  - 公共資助的計劃生育服務不斷增加
- 產業陷阱與挑戰
  - 農村人口缺乏意識
  - 與使用避孕藥物和裝置相關的不良反應
成長潛力分析
監管環境
技術景觀
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
競爭定位矩陣
戰略展望矩陣

第 5 章：市場估計與預測：按應用分類，2018 - 2032

主要趨勢
產後出血治療
懷孕流產

第 6 章：市場估計與預測：按配銷通路分類，2018 年 - 2032 年

主要趨勢
醫院藥房
零售藥局
網路藥局

第 7 章：市場估計與預測：按地區分類，2018 年 - 2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 8 章：公司簡介

Advancion Corporation
Amneal Pharmaceuticals, Inc.
Apionex Pharma Pvt Ltd.
Biosynth Limited
Bio-Techne Corporation
BioSpectra Inc.
Dr. Reddy's Laboratories Ltd.
Merck & Co., Inc.
Monvi Laboratories Private Limited
Manus Aktteva Biopharma Llp
Pfizer Inc.
Ryvis Pharma Private Limited
SimSon Pharma Limited
Taj Pharmaceuticals Limited
The International Chemical Secretariat
Universal Biosensors, Inc.
Willis Towers Watson Public Limited Company
Woodward, Inc.

簡介目錄

Product Code: 8526

Carboprost tromethamine market is anticipated to grow at 7.9% CAGR from 2024 to 2032, driven by the increasing prevalence of conditions, such as postpartum hemorrhage (PPH) and uterine atony, particularly in developing regions. As per WHO, annually, around 14 million women endure postpartum hemorrhage (PPH), leading to roughly 70,000 maternal fatalities worldwide. These conditions pose significant risks to maternal health during childbirth, necessitating effective interventions to control bleeding and prevent complications. Advancements in obstetric care and rising awareness among healthcare professionals about the efficacy in managing PPH is fueling the adoption of carboprost tromethamine in clinical settings.

The treatment of gynecological disorders like menstrual disorders and incomplete abortion will further spur the market expansion. As healthcare providers seek versatile treatment options to address a range of reproductive health issues, the demand for carboprost tromethamine is rising. Furthermore, favorable government initiatives are improving maternal healthcare infrastructure and reducing maternal mortality rates, particularly in emerging economies.

The carboprost tromethamine industry is segmented into application, distribution channel and region.

The market share from pregnancy abortion application segment is anticipated to gain momentum and grow at 8%CAGR through 2032. Carboprost tromethamine is widely recognized as an effective uterotonic agent for inducing uterine contractions and facilitating the expulsion of fetal tissue during medical abortion procedures. With the increasing acceptance and availability of medical abortion as a safe and non-invasive alternative to surgical procedures, the growing demand for pharmacological agents to support the process will add to the segment growth.

As per distribution channel, the carboprost tromethamine market value from the online pharmacies segment is poised to witness 6.8% growth rate over the forecast period. The convenience and accessibility offered by online pharmacies makes it easier for healthcare providers to procure essential medications like carboprost tromethamine, particularly in regions with limited access to traditional brick-and-mortar pharmacies. The availability of a wide range of pharmaceutical products on online pharmacies also enables healthcare professionals to conveniently source carboprost tromethamine along with other medications for streamlining the procurement processes.

Asia Pacific carboprost tromethamine industry size will record notable expansion at 8.5% CAGR between 2024 and 2032, attributed to the high burden of maternal mortality rates, particularly in countries with limited access to obstetric care. The increasing adoption of medical abortion procedures and expanding access to reproductive healthcare services are contributing to the rising product demand. Supportive government initiatives aimed at improving maternal and reproductive healthcare infrastructure, along with higher healthcare expenditure and awareness will further fuel the regional market growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising prevalence of postpartum hemorrhage
  - 3.2.1.2 Increasing initiatives by government and various organizations
  - 3.2.1.3 Rising publicly funded family planning services
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Lack of awareness among rural population
  - 3.2.2.2 Adverse effects associated with use of contraceptive drugs and devices
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
- 3.6.1 Supplier power
- 3.6.2 Buyer power
- 3.6.3 Threat of new entrants
- 3.6.4 Threat of substitutes
- 3.6.5 Industry rivalry
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

5.1 Key trends
5.2 Postpartum hemorrhage treatment
5.3 Pregnancy abortion

Chapter 6 Market Estimates and Forecast, By Distribution Channel, 2018 - 2032 ($ Mn)

6.1 Key trends
6.2 Hospital pharmacies
6.3 Retail pharmacies
6.4 Online pharmacies

Chapter 7 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Rest of Europe
7.4 Asia Pacific
- 7.4.1 Japan
- 7.4.2 China
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 Saudi Arabia
- 7.6.2 South Africa
- 7.6.3 UAE
- 7.6.4 Rest of Middle East and Africa